Literature DB >> 19295131

Reprogramming to a muscle fate by fusion recapitulates differentiation.

Jason H Pomerantz1, Semanti Mukherjee, Adam T Palermo, Helen M Blau.   

Abstract

Fusion of mammalian cells to form stable, non-dividing heterokaryons results in nuclear reprogramming without the exchange of genetic material. In this report, we show that reprogramming in somatic cell heterokaryons involves activation of the canonical skeletal muscle transcription factors as well as contraction-excitation genes. Thus, the effect of heterokaryon formation on gene expression is to induce a recapitulation of differentiation. Heterokaryons formed with a relatively refractory cell type, the hepatocyte cell line HepG2, revealed the importance of both MyoD expression and other unidentified cytoplasmic components, neither of which are sufficient for efficient muscle gene activation, but are synergistic. We provide evidence that de-repression by transient histone deacetylase inhibition can induce MyoD expression and increase the extent and efficiency of muscle gene transcription. Taken together, the results suggest that understanding the mechanistic basis, using a combination of approaches, and taking into account cell history, will facilitate an increase in the efficiency and fidelity of conversion from one differentiated phenotype to another desired cell type. Inherent advantages of the heterokaryon system merit further investigation in the pursuit of directed cloning.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19295131      PMCID: PMC2720934          DOI: 10.1242/jcs.041376

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  39 in total

Review 1.  Nuclear transplantation: lessons from frogs and mice.

Authors:  Konrad Hochedlinger; Rudolf Jaenisch
Journal:  Curr Opin Cell Biol       Date:  2002-12       Impact factor: 8.382

2.  Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice.

Authors:  Lina Kassar-Duchossoy; Barbara Gayraud-Morel; Danielle Gomès; Didier Rocancourt; Margaret Buckingham; Vasily Shinin; Shahragim Tajbakhsh
Journal:  Nature       Date:  2004-09-23       Impact factor: 49.962

3.  Cytoplasmic activation of human nuclear genes in stable heterocaryons.

Authors:  H M Blau; C P Chiu; C Webster
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

4.  Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant.

Authors:  James M Weimann; Clas B Johansson; Angelica Trejo; Helen M Blau
Journal:  Nat Cell Biol       Date:  2003-10-15       Impact factor: 28.824

Review 5.  A review of depsipeptide and other histone deacetylase inhibitors in clinical trials.

Authors:  Richard Piekarz; Susan Bates
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

6.  Trichostatin A improves histone acetylation in bovine somatic cell nuclear transfer early embryos.

Authors:  Amy E Iager; Neli P Ragina; Pablo J Ross; Zeki Beyhan; Kerrianne Cunniff; Ramon M Rodriguez; Jose B Cibelli
Journal:  Cloning Stem Cells       Date:  2008-09

7.  Reprogramming cell differentiation in the absence of DNA synthesis.

Authors:  C P Chiu; H M Blau
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

8.  Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases.

Authors:  Simona Iezzi; Giulio Cossu; Clara Nervi; Vittorio Sartorelli; Pier Lorenzo Puri
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

9.  The first half-century of nuclear transplantation.

Authors:  J B Gurdon; J A Byrne
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-23       Impact factor: 12.779

10.  Induction of muscle genes in neural cells.

Authors:  W E Wright
Journal:  J Cell Biol       Date:  1984-02       Impact factor: 10.539

View more
  14 in total

Review 1.  Nuclear reprogramming to a pluripotent state by three approaches.

Authors:  Shinya Yamanaka; Helen M Blau
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

2.  Characterization of Pax3-expressing cells from adult blood vessels.

Authors:  Olivier Goupille; Giorgia Pallafacchina; Frédéric Relaix; Simon J Conway; Ana Cumano; Benoit Robert; Didier Montarras; Margaret Buckingham
Journal:  J Cell Sci       Date:  2011-12-08       Impact factor: 5.285

3.  Perspective for special Gurdon issue for differentiation: can cell fusion inform nuclear reprogramming?

Authors:  David Burns; Helen M Blau
Journal:  Differentiation       Date:  2014-08-21       Impact factor: 3.880

Review 4.  Using heterokaryons to understand pluripotency and reprogramming.

Authors:  Francesco M Piccolo; Carlos F Pereira; Irene Cantone; Karen Brown; Tomomi Tsubouchi; Jorge Soza-Ried; Matthias Merkenschlager; Amanda G Fisher
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-08-12       Impact factor: 6.237

5.  In vivo myomaker-mediated heterologous fusion and nuclear reprogramming.

Authors:  Yasuyuki Mitani; Ronald J Vagnozzi; Douglas P Millay
Journal:  FASEB J       Date:  2016-10-17       Impact factor: 5.191

6.  Single mammalian cells compensate for differences in cellular volume and DNA copy number through independent global transcriptional mechanisms.

Authors:  Olivia Padovan-Merhar; Gautham P Nair; Andrew G Biaesch; Andreas Mayer; Steven Scarfone; Shawn W Foley; Angela R Wu; L Stirling Churchman; Abhyudai Singh; Arjun Raj
Journal:  Mol Cell       Date:  2015-04-09       Impact factor: 17.970

7.  Production of interspecies somatic/pluripotent heterokaryons using polyethylene glycol (PEG) and selection by imaging flow cytometry for the study of nuclear reprogramming.

Authors:  Cristina Villafranca; Melissa R Makris; Maria Jesus Garrido Bauerle; Roderick V Jensen; Willard H Eyestone
Journal:  Cytotechnology       Date:  2020-10-27       Impact factor: 2.058

Review 8.  Employing core regulatory circuits to define cell identity.

Authors:  Nathalia Almeida; Matthew W H Chung; Elena M Drudi; Elise N Engquist; Eva Hamrud; Abigail Isaacson; Victoria S K Tsang; Fiona M Watt; Francesca M Spagnoli
Journal:  EMBO J       Date:  2021-05-02       Impact factor: 14.012

9.  Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming.

Authors:  X Zhang; F D Cruz; M Terry; F Remotti; I Matushansky
Journal:  Oncogene       Date:  2012-07-09       Impact factor: 9.867

10.  Cell fusion reprogramming leads to a specific hepatic expression pattern during mouse bone marrow derived hepatocyte formation in vivo.

Authors:  Oscar Quintana-Bustamante; Esther Grueso; Ramon Garcia-Escudero; Elvira Arza; Alberto Alvarez-Barrientos; Isabel Fabregat; Maria Garcia-Bravo; Nestor W Meza; Jose C Segovia
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.